Moberg Pharma AB (publ) banner

Intrinsic Value

Is MB8 undervalued or overvalued?

See the intrinsic value estimate for Moberg Pharma AB (publ) and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MB8 Intrinsic Value
LOCKED
Unlock
Today vs. history

MB8 looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with MB8’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MB8
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €0.94
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MB8

Fundamental Analysis

What Moberg Pharma AB Does

Pharmaceuticals Health Care

Moberg Pharma is a Swedish specialty pharmaceutical company that develops and sells branded over-the-counter treatments, mainly for nail and skin problems such as nail fungus. Its products are designed for self-care, so the company is focused on treatments people can buy without a doctor’s prescription. It also works with partners and distributors to sell its brands in different markets.

Headquarters
Sweden SE
IPO date
May 26, 2011
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Moberg Pharma AB (publ)

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one MB8 stock?

The intrinsic value for Moberg Pharma AB (publ) (MB8) under the Base Case is hidden EUR.

Is MB8 stock undervalued or overvalued?

Compared with the current market price of 0.944 EUR, the stock appears hidden.

Back to Top